Advertisement

Topics

Calif. biotech gets $25M in funding to develop cancer treatments

05:04 EDT 29 Jun 2017 | SmartBrief

Vivace Therapeutics has gained $25 million from China's Cenova Capital in a Series B funding round to finance its development -More

Original Article: Calif. biotech gets $25M in funding to develop cancer treatments

NEXT ARTICLE

More From BioPortfolio on "Calif. biotech gets $25M in funding to develop cancer treatments"

Advertisement
Quick Search
Advertisement
Advertisement